Terms: = Bone cancer AND CDK6, MGC59692, 1021, Q00534, ENSG00000105810, PLSTIRE
129 results:
1. Development of a novel six DNA damage response-related prognostic signature in osteosarcoma.
Li T; Tang Z; Li S; Lu M
Cell Mol Biol (Noisy-le-grand); 2024 Mar; 70(3):110-115. PubMed ID: 38650147
[TBL] [Abstract] [Full Text] [Related]
2. CircPRMT5 promotes progression of osteosarcoma by recruiting CNBP to regulate the translation and stability of cdk6 mRNA.
Liu Y; Jiang H; Hu K; Zou H; Zhang W; Liu J; Jian X
PLoS One; 2024; 19(4):e0298947. PubMed ID: 38626179
[TBL] [Abstract] [Full Text] [Related]
3. Vitexicarpin Induces Apoptosis and Inhibits Metastatic Properties via the AKT-PRAS40 Pathway in Human Osteosarcoma.
Yun HM; Kwon HS; Lee JY; Park KR
Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612399
[TBL] [Abstract] [Full Text] [Related]
4. Radiologic patterns of distant organ metastasis in advanced breast cancer patients: Prospective review of computed tomography images.
Jimah BB; Amoako E; Ofori EO; Akakpo PK; Aniakwo LA; Ulzen-Appiah K; Imbeah EG; Morna MT; Koggoh P; Akligoh H; Tackie R; Manu A; Paemka L; Sarkodie BD; Offei AK; Hutchful D; Ngoi J; Bediako Y; Rahman GA
Cancer Rep (Hoboken); 2024 Feb; 7(2):e1988. PubMed ID: 38351553
[TBL] [Abstract] [Full Text] [Related]
5. Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).
Mill CP; Fiskus WC; DiNardo CD; Reville P; Davis JA; Birdwell CE; Das K; Hou H; Takahashi K; Flores L; Ruan X; Su X; Loghavi S; Khoury JD; Bhalla KN
Blood Cancer J; 2024 Feb; 14(1):25. PubMed ID: 38316746
[TBL] [Abstract] [Full Text] [Related]
6. Small-molecule inhibition of kinesin KIF18A reveals a mitotic vulnerability enriched in chromosomally unstable cancers.
Payton M; Belmontes B; Hanestad K; Moriguchi J; Chen K; McCarter JD; Chung G; Ninniri MS; Sun J; Manoukian R; Chambers S; Ho SM; Kurzeja RJM; Edson KZ; Dahal UP; Wu T; Wannberg S; Beltran PJ; Canon J; Boghossian AS; Rees MG; Ronan MM; Roth JA; Minocherhomji S; Bourbeau MP; Allen JR; Coxon A; Tamayo NA; Hughes PE
Nat Cancer; 2024 Jan; 5(1):66-84. PubMed ID: 38151625
[TBL] [Abstract] [Full Text] [Related]
7. [Efficacy and safety of pegylated interferon alpha-2b for patients with myeloproliferative neoplasm].
Teng GS; Zhang YH; Wang Y; Du CX; Li YQ; Hu NB; Xiang GP; Shao ZH; Bai J
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3645-3651. PubMed ID: 38018063
[No Abstract] [Full Text] [Related]
8. cdk6: an attractive therapeutic target for T-ALL/LBL.
Li W; Hu JK; Hu MG
Expert Opin Ther Targets; 2023; 27(11):1087-1096. PubMed ID: 37975616
[TBL] [Abstract] [Full Text] [Related]
9. The Targeted Therapies for Osteosarcoma
Wang S; Ren Q; Li G; Zhao X; Zhao X; Zhang Z
Curr Mol Pharmacol; 2024; 17(1):e210823220109. PubMed ID: 37602543
[TBL] [Abstract] [Full Text] [Related]
10. Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
Bhasin SS; Thomas BE; Summers RJ; Sarkar D; Mumme H; Pilcher W; Emam M; Raikar SS; Park SI; Castellino SM; Graham DK; Bhasin MK; DeRyckere D
Sci Rep; 2023 Aug; 13(1):12556. PubMed ID: 37532715
[TBL] [Abstract] [Full Text] [Related]
11. CRISPR-Cas9 screening identified lethal genes enriched in necroptosis pathway and of prognosis significance in osteosarcoma.
Cheng L; Xiong W; Li S; Wang G; Zhou J; Li H
J Gene Med; 2023 Dec; 25(12):e3563. PubMed ID: 37421290
[TBL] [Abstract] [Full Text] [Related]
12. Mapping the landscape of genetic dependencies in chordoma.
Sharifnia T; Wawer MJ; Goodale A; Lee Y; Kazachkova M; Dempster JM; Muller S; Levy J; Freed DM; Sommer J; Kalfon J; Vazquez F; Hahn WC; Root DE; Clemons PA; Schreiber SL
Nat Commun; 2023 Apr; 14(1):1933. PubMed ID: 37024492
[TBL] [Abstract] [Full Text] [Related]
13. Exosomal RNAs in the development and treatment of pituitary adenomas.
Chang M; Jiang S; Guo X; Gao J; Liu P; Bao X; Feng M; Wang R
Front Endocrinol (Lausanne); 2023; 14():1142494. PubMed ID: 36875488
[TBL] [Abstract] [Full Text] [Related]
14. Radioisotope-guided Lymphadenectomy for Pelvic Lymph Node Staging in Patients With Intermediate- and High-risk Prostate cancer (The Prospective SENTINELLE Study).
Lannes F; Baboudjian M; Ruffion A; Rouy M; Giammarile F; Rousseau T; Kraeber-Bodéré F; Rousseau C; Rusu D; Colombié M; Brenot-Rossi I; Rossi D; Mottet N; Bastide C
J Urol; 2023 Feb; 209(2):364-373. PubMed ID: 36331157
[TBL] [Abstract] [Full Text] [Related]
15. MicroRNA-15 suppresses viability, migration and invasion of the human MG-63 osteosarcoma cells via inhibition of cyclin dependent kinase 6 (cdk6).
Shen Z; Wang C; Liu B; Du J; Li Z; Zhao J
Acta Biochim Pol; 2022 Oct; 69(4):761-766. PubMed ID: 36272153
[TBL] [Abstract] [Full Text] [Related]
16. A novel immune cell signature for predicting osteosarcoma prognosis and guiding therapy.
Pan R; Pan F; Zeng Z; Lei S; Yang Y; Yang Y; Hu C; Chen H; Tian X
Front Immunol; 2022; 13():1017120. PubMed ID: 36189307
[TBL] [Abstract] [Full Text] [Related]
17. BMP2 inhibits cell proliferation by downregulating EZH2 in gastric cancer.
Chen Z; Yuan L; Li X; Yu J; Xu Z
Cell Cycle; 2022 Nov; 21(21):2298-2308. PubMed ID: 35856444
[TBL] [Abstract] [Full Text] [Related]
18. Continuous treatment with abemaciclib leads to sustained and efficient inhibition of breast cancer cell proliferation.
Torres-Guzmán R; Ganado MP; Mur C; Marugan C; Baquero C; Yang Y; Zeng Y; Bian H; Du J; de Dios A; Puig O; Lallena MJ
Oncotarget; 2022; 13():864-875. PubMed ID: 35813283
[TBL] [Abstract] [Full Text] [Related]
19. Oncogenic lncRNA ZNFX1 antisense RNA 1 promotes osteosarcoma cells proliferation and metastasis by stabilizing serine and arginine‑rich splicing factor 3.
Zhang Y; Xu W; Wang Y; Li J; He G; Guan M; Zeng X; Bian W; Song Y; Liu J
Bioengineered; 2022 Mar; 13(3):5962-5974. PubMed ID: 35184675
[TBL] [Abstract] [Full Text] [Related]
20. Abemaciclib in patients with p16ink4A-deficient mesothelioma (MiST2): a single-arm, open-label, phase 2 trial.
Fennell DA; King A; Mohammed S; Greystoke A; Anthony S; Poile C; Nusrat N; Scotland M; Bhundia V; Branson A; Brookes C; Darlison L; Dawson AG; Gaba A; Hutka M; Morgan B; Bajaj A; Richards C; Wells-Jordan P; Thomas A;
Lancet Oncol; 2022 Mar; 23(3):374-381. PubMed ID: 35157829
[TBL] [Abstract] [Full Text] [Related]
[Next]
